Tianqing Chu

Phase 1b Study of Sintilimab Plus Anlotinib as First-line Therapy in Patients With Advanced NSCLC

Tianqing Chu, Runbo Zhong, Hua Zhong et al. · Journal of Thoracic Oncology · 2021 · 216 citations · Full text

Phase 1B, Advanced Nsclc, Sintilimab Plus Anlotinib +6

Combination of chemotherapy and gefitinib as first-line treatment for patients with advanced lung adenocarcinoma and sensitive EGFR mutations: A randomized controlled trial

Baohui Han, Bo Jin, Tianqing Chu et al. · International Journal of Cancer · 2017 · 152 citations · Full text

Role of anlotinib-induced CCL2 decrease in anti-angiogenesis and response prediction for nonsmall cell lung cancer therapy

Jun Lü, Hua Zhong, Tianqing Chu et al. · European Respiratory Journal · 2018 · 94 citations

Use of capture-based next-generation sequencing to detect ALK fusion in plasma cell-free DNA of patients with non-small-cell lung cancer

Shaohua Cui, Wei Zhang, Liwen Xiong et al. · Oncotarget · 2016 · 75 citations · Full text

Alk Fusion, Capture-based Next-generation Sequencing, Plasma Cell-free Dna +14

LPS inactivation by a host lipase allows lung epithelial cell sensitization for allergic asthma

Guojun Qian, Wei Jiang, Benkun Zou et al. · The Journal of Experimental Medicine · 2018 · 68 citations · Full text